期刊文献+

RNA干扰抑制MDR1表达并逆转Bel7402/5-Fu肝癌细胞耐药性的研究 被引量:1

Suppression of MDR1 expression and restoration of sensitivity to chemotherapy in multidrug-resistant hepatocellular carcinoma cell line Bel7402/5-Fu by RNA interference
下载PDF
导出
摘要 目的:研究小片段RNA干扰对肝癌耐药细胞系Bel7402/5-Fu中多药耐药基因(multidrugresistance1,MDR1)及其蛋白产物P-gp表达的抑制作用和逆转其耐药性的效果。方法:合成针对MDR1启动子区域的RNA干扰小片段,转染肝癌耐药细胞Bel7402/5-Fu。通过RT-PCR和Westernblot方法,在mRNA和蛋白水平评价RNA干扰对MDR1表达的影响。MTT法检测RNA干扰逆转Bel7402/5-Fu细胞耐药性的效果,按实验组和对照组细胞的半数抑制剂量(IC50)计算RNA干扰对细胞耐药倍数的改变和RNA干扰组细胞的耐药逆转倍数。以流式细胞仪比较各组细胞在相同浓度化疗药物作用时细胞的凋亡情况。结果:在耐药肝癌细胞Bel7402/5-Fu中,RNA干扰明显抑制了MDR1mRNA和蛋白产物P-gp的表达水平,其表达仅为对照组细胞的22.55%和25.49%(P<0.01)。在相同浓度化疗药物的作用下,RNA干扰组Bel7402/5-Fu细胞凋亡比例显著高于对照组(P<0.01),表明细胞耐药性显著下降,对5-Fu的耐药逆转倍数为14.88倍。结论:肝癌耐药细胞Bel7402/5-Fu中,RNA干扰对MDR1mRNA及其蛋白产物P-gp的表达水平有显著抑制作用,具有良好的逆转耐药性的效果。 Objective To investigate the suppression of MDR1 and P-glycoprotein induced by small interfering RNA and the restoration of sensitivity to chemotherapeutic drugs in multidrug-resistant hepatoeellular carcinoma cell line Be17402/5-Fu. Methods MDR1-targeted small interfering RNA duplexes were introduced into multidrug-resistant hepatocellular carcinoma cell line Be17402/5-Fu. The suppression of MDR1 and its gene product P-glycoprotein was examined by RT-PCR and Western blot. MTT assay was performed to measure the reverse effect of small interfering RNA based on the results of IC50. Cell apoptosis was assessed by flow cytometry after various cell lines were treated with chemotherapeutic drugs. Results The overexpression of MDR1 and P-glycoprotein was suppressed efficiently by the introduction of small interfering RNA, which caused sequence-specific gene silence. The level of MDR1 in the transfected Be17402/5-Fu cells reduced to 22.55% and P-glycoprotein to 25.49% compared with those of the controls. The apoptosis rate of Be17402/5-Fu cells increased significantly in the siRNA group during the chemotherapy ( P 〈 0. 01 ). Their resistance to 5-Fu was reversed by 14.88 folds, which indicated the restoration of sensitivity to drugs. Conclusion Small interfering RNA can inhibit MDR1 expression effective and reverse the multidrug resistance mediated by P-glycoprotein.
作者 任勇亚
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2006年第6期872-876,共5页 Journal of Central South University :Medical Science
关键词 多药耐药 RNA干扰 肝癌 multidrug resistance RNA interference hepatocellular carcinomal
  • 相关文献

参考文献9

  • 1[1]Levchenko A,Mehta B M,Niu X,et al.Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells[J].Proc Natl Acad Sci USA,2005,102(6):1933-1938.
  • 2[2]Rosenberg M F,Callaghan R,Modok S,et al.Three-dimensional structure of P-glycoprotein:the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state[J].J Biol Chem,2005,280(4):2857-2862.
  • 3[3]Huppi K,Martin S E,Caplen N J.Defining and assaying RNAi in mammalian cells[J].Mol Cell,2005,17(1):1-10.
  • 4吕辉,贺智敏.RNA干扰技术的演进及其在基因功能和基因治疗研究中的应用[J].中南大学学报(医学版),2005,30(1):102-105. 被引量:2
  • 5[5]Elbashir S M,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,200l,411 (6836):494-498.
  • 6[6]Hannon G J.RNA interference[J].Nature,2002,418(6894):244-251.
  • 7[7]Yu G,Ahmad S,Aquino A,et al.Transfection with protein kinase C α confers increased multidrug resistance to MCF-7cells expressing P-glycoprotein[J].Cancer Commun,1991,3(6):181-189.
  • 8[8]Gillet J P,Efferth T,Steinbach D,et al.Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes[J].Cancer Res,2004,64(24):8987-8993.
  • 9[9]Novina C D,Murray M F,Dykxhoorn D M,et al.siRNAdirected inhibition of HIV-1 infection[J].Nat Med,2002,8(7):681-686.

二级参考文献29

  • 1Guo S, Kemphues KJ. Par-1, a gene required for establishingpolarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed[J]. Cell, 1995, 81(4):611-620.
  • 2Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998, 391(6669):806-811.
  • 3Hannon GJ. RNA interference [J]. Nature, 2002, 418(6894):244-251.
  • 4Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs[J]. Genes Dev, 2001, 15(2):188-200.
  • 5Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate[J]. EMBO Rep, 2001, 20(23):6877-6888.
  • 6Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J]. Proc Natl Acad Sci USA, 2002, 99(9):6047-6052.
  • 7Donze O, Picard D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase[J]. Nucleic Acids Res, 2002, 30(10):46-49.
  • 8Brummelkamp TR, Bernards R, Agami R. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells[J]. Science, 2002, 296(5567):550-553.
  • 9Castanotto D, Li H, Rossi JJ. Functional siRNA expression from transfected PCR products[J]. RNA, 2002, 8(11):1454-1460.
  • 10Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells[J]. Nat Biotechnol, 2002, 20(5):497-500.

共引文献1

同被引文献10

  • 1AAGAARD L, ROSSI J J. RNAi therapeutics: PrinCiples, prospects and challenges [ J ]. Advanced Drug Delivery Reviews ,2007,59 (2): 76-83.
  • 2ACHARYA G,SHIN C S, VEDANTHAM K, et al. A study of drug release from homogeneous PLGA microstructures [ J ]. Journal of Controlled Release,2010,146 (2) :201-206.
  • 3PAN G D, YANG J Q, YAN L N. Reversal of multi-drug resistance by pSUPER-shRNA-mdrl in vivo and in vitro [ J ]. World Journal of Gastroenterol, 2009,15 ( 4 ) :431-440.
  • 4WHITEHEAD K A, LANGER R. Knocking down barriers : advances in siRNA delivery [ J ]. Nature,2009,8 ( 2 ) : 129-138.
  • 5CHEN G, WANG Y, ZHOU M, et al. EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma [ J ]. Oncology Reports, 2010,23 ( 2 ) : 563- 570.
  • 6CHITWOOD'D H ,TIMMERMANS M C. Small RNAs are on the move [J]. Nature,2010,467(7 314) :415-419.
  • 7DINARVAND R, SEPEHRI N, MANOOCHEHRI S, et al. Polylactide-co-glycolide Nanoparticles for controlled delivery of anti cancer agents[ J]. International Journal of Nanomedicine ,2011,6 ( 1 ) : 877- 895.
  • 8金忱,罗国培,陈卫,龙江,傅德良,倪泉兴.聚乳酸羟基乙酸-泊洛沙姆纳米微粒作为siRNA载体的可行性[J].中华实验外科杂志,2009,26(3):315-317. 被引量:4
  • 9王新平,严律南,李德华,苟兴华,潘光栋,夏冬,刘江文,严茂林,阎乃红,陈清英.RNA干扰逆转肝癌多药耐药[J].中华肝胆外科杂志,2011,17(3):243-247. 被引量:4
  • 10汪洋,褚忠华,刘建平,张大伟,韦金星,陕基德.小干扰RNA沉默MDRl基因对SMMC-7721肝癌细胞株多药耐药性的影响[J].中华实验外科杂志,2011,28(4):550-552. 被引量:12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部